Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Diabetologia
Published in: Diabetologia 8/2018

01-08-2018 | Letter

Medicalising pregnancy with new diagnostic criteria for gestational diabetes mellitus: do we need more evidence?

Authors: Hema Venkataraman, Ponnusamy Saravanan

Published in: Diabetologia | Issue 8/2018

Login to get access

Excerpt

To the Editor: We read with interest the article by Koning et al [1]. The authors report that the additional women diagnosed with gestational diabetes mellitus (GDM) by the WHO 2013 definition (i.e. fasting plasma glucose [FPG] ≥5.1 mmol/l but ≤6.9 mmol/l) were more likely to be obese and have higher BMI and hypertension compared with women with normal glucose tolerance (NGT). …
Literature
1.
Koning SH, van Zanden JJ, Hoogenberg K et al (2018) New diagnostic criteria for gestational diabetes mellitus and their impact on the number of diagnoses and pregnancy outcomes. Diabetologia 61:800–809CrossRefPubMed
2.
Catalano PM, McIntyre HD, Cruickshank JK et al (2012) The Hyperglycemia and Adverse Pregnancy Outcome study: associations of GDM and obesity with pregnancy outcomes. Diabetes Care 35:780–786CrossRefPubMedPubMedCentral
3.
HAPO Study Cooperative Research Group (2010) Hyperglycaemia and Adverse Pregnancy Outcome (HAPO) study: associations with maternal body mass index. BJOG 117:575–584CrossRef
4.
Hilden K, Hanson U, Persson M, Fadl H (2016) Overweight and obesity: a remaining problem in women treated for severe gestational diabetes. Diabet Med 33:1045–1051CrossRefPubMedPubMedCentral
5.
Weiss JL, Malone FD, Emig D et al (2004) Obesity, obstetric complications and cesarean delivery rate—a population-based screening study. Am J Obstet Gynecol 190:1091–1097CrossRefPubMed
6.
7.
Meek CL, Lewis HB, Patient C, Murphy HR, Simmons D (2015) Diagnosis of gestational diabetes mellitus: falling through the net. Diabetologia 58:2003–2012CrossRefPubMedPubMedCentral
8.
Martin KE, Grivell RM, Yelland LN, Dodd JM (2015) The influence of maternal BMI and gestational diabetes on pregnancy outcome. Diabetes Res Clin Pract 108:508–513CrossRefPubMed
9.
Duran A, Sáenz S, Torrejón MJ et al (2014) Introduction of IADPSG criteria for the screening and diagnosis of gestational diabetes mellitus results in improved pregnancy outcomes at a lower cost in a large cohort of pregnant women: the St. Carlos Gestational Diabetes Study. Diabetes Care 37:2442–2450CrossRefPubMed
10.
Hung TH, Hsieh TT (2015) The effects of implementing the International Association of Diabetes and Pregnancy Study Groups criteria for diagnosing gestational diabetes on maternal and neonatal outcomes. PLoS One 10:e0122261CrossRefPubMedPubMedCentral
11.
12.
Tanentsapf I, Heitmann BL, Adegboye AR (2011) Systematic review of clinical trials on dietary interventions to prevent excessive weight gain during pregnancy among normal weight, overweight and obese women. BMC Pregnancy Childbirth 11:81CrossRefPubMedPubMedCentral
13.
Poston L, Bell R, Croker H et al (2015) Effect of a behavioural intervention in obese pregnant women (the UPBEAT study): a multicentre, randomised controlled trial. Lancet Diabetes Endocrinol 3:767–777CrossRefPubMed
14.
Keag OE, Norman JE, Stock SJ (2018) Long-term risks and benefits associated with cesarean delivery for mother, baby, and subsequent pregnancies: systematic review and meta-analysis. PLoS Med 15:e1002494CrossRefPubMedPubMedCentral
Metadata
Title
Medicalising pregnancy with new diagnostic criteria for gestational diabetes mellitus: do we need more evidence?
Authors
Hema Venkataraman
Ponnusamy Saravanan
Publication date
01-08-2018
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 8/2018
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-018-4666-3

Other articles of this Issue 8/2018

Diabetologia 8/2018 Go to the issue

Article

An adult-based insulin resistance genetic risk score associates with insulin resistance, metabolic traits and altered fat distribution in Danish children and adolescents who are overweight or obese

Article

Exercise training decreases pancreatic fat content and improves beta cell function regardless of baseline glucose tolerance: a randomised controlled trial

Article

Systematic review assessing the effectiveness of dietary intervention on gut microbiota in adults with type 2 diabetes

Article

Protective role of the ELOVL2/docosahexaenoic acid axis in glucolipotoxicity-induced apoptosis in rodent beta cells and human islets

Short Communication

A selective CD28 antagonist and rapamycin synergise to protect against spontaneous autoimmune diabetes in NOD mice

Short Communication

Vegf-A mRNA transfection as a novel approach to improve mouse and human islet graft revascularisation
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits